Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges
With the global trend of population aging becoming increasingly pronounced, the incidence of central nervous system (CNS) disorders continues to rise, posing a significant challenge to public health systems worldwide. Currently, many CNS disorders lack effective treatments, prompting researchers to...
Saved in:
| Main Authors: | Qiang Zhang, Wan Zhang, Xinya Yuan, Xiaohong Peng, Guangyuan Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1553 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging evidence of Urolithin A in sports nutrition: bridging preclinical findings to athletic applications
by: Manda Wang, et al.
Published: (2025-05-01) -
Exploring the Neuroprotective Role of Selenium: Implications and Perspectives for Central Nervous System Disorders
by: Guanning Huang, et al.
Published: (2025-08-01) -
Oxidative cell death in the central nervous system: mechanisms and therapeutic strategies
by: Nan Liu, et al.
Published: (2025-04-01) -
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy
by: Alba Rodríguez-García, et al.
Published: (2025-02-01) -
Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection
by: Jorge Y. Magdaleno Roman, et al.
Published: (2024-06-01)